Final stage of testing for some laboratories in the U.S.
The federal government plans to fund and conduct the decisive studies of three experimental coronavirus vaccines starting in mid July.
The phase 3 trials are expected to involve tens of thousands of subjects at dozens of states around the U.S. according to John Mascola, director of the vaccine research center at the National Institute of Allergy and Infectious Diseases.
The final stage is meant to determine a vaccine’s safety and effectiveness.
One of those laboratories, Johnson & Johnson, which began working on developing a COVID-19 vaccine in January, announced its early stage human trial will begin in the second half of July, earlier than its initial forecast of September. If all goes well and it is safe, J&J said they could produce 600 million to 900 million doses by April 2021.
As the Lord Leads, Pray with Us…
- For the work being done by laboratories and researchers across the U.S. to have a safe outcome for a COVID-19 vaccine.
- For government overseers who are working with the private industries in the formulation of a vaccine.
Sources: Wall Street Journal, CNBC
